[en] Background : No clinical test is currently available and validated to measure the maximum walking speed (WS) of multiple sclerosis (MS) patients. Since the Timed 25-Foot Walk Test (T25FW) is performed with a static start, it takes a significant proportion of the distance for MS patients to reach their maximum pace.
Objectives : In order to capture the maximum WS and to quantify the relative impact of the accelerating phase during the first meters, we compared the classical T25FW with a modified version (T25FW+) allowing a dynamic start after a 3 meters run-up.
Methods : Sixty-four MS patients and 30 healthy subjects performed successively the T25FW and the T25FW+.
Results : The T25FW+ was performed faster than the T25FW for the vast majority of MS and healthy subjects. In the MS population, the mean relative gain of speed due to the dynamic start on T25FW+ was independent from the EDSS and from the level of ambulation impairment. Compared to healthy subjects, the relative difference between dynamic versus static start was more important in the MS population even in patients devoid of apparent gait impairment according to the T25FW.
Conclusion : The T25FW+ allows a more accurate measurement of the maximum WS of MS patients, which is a prerequisite to reliably evaluate deceleration over longer distance tests. Indirect arguments suggest that the time to reach the maximum WS may be partially influenced by the cognitive impairment status. The maximum WS and the capacity of MS patients to accelerate on a specific distance may be independently regulated and assessed separately in clinical trials and rehabilitation programs.
Disciplines :
Neurology
Author, co-author :
Phan-Ba, Rémy ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques
CALAY, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Neurologie Sart Tilman
GRODENT, Patrick ; Centre Hospitalier Universitaire de Liège - CHU > Médecine de l'appareil locomoteur
DELRUE, Gaël ; Centre Hospitalier Universitaire de Liège - CHU > Neurologie Sart Tilman
LOMMERS, Emilie ; Centre Hospitalier Universitaire de Liège - CHU > Neurologie Sart Tilman
DELVAUX, Valérie ; Centre Hospitalier Universitaire de Liège - CHU > Neurologie Sart Tilman
Moonen, Gustave ; Université de Liège - ULiège > Département des sciences cliniques > Neurologie
Nagels, Guy
Belachew, Shibeshih ; Université de Liège - ULiège > Département des sciences cliniques > Neurologie
Language :
English
Title :
A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ, Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12), Neurology 60 (2003), 31-6.
Heesen C, Bohm J, Reich C, Kasper J, Goebel M, Gold SM, Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable, Mult Scler 14 (2008), 988-91.
Sutliff MH, Contribution of impaired mobility to patient burden in multiple sclerosis, Curr Med Res Opin (2009)
Kurtzke JF, Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology 33 (1983), 1444-52.
Kalron A, Dvir Z, Achiron A, Walking while talking-difficulties incurred during the initial stages of multiple sclerosis disease process, Gait Posture 32 (2010), 332-5.
Martin CL, Phillips BA, Kilpatrick TJ, Butzkueven H, Tubridy N, McDonald E, Galea MP, Gait and balance impairment in early multiple sclerosis in the absence of clinical disability, Mult Scler 12 (2006), 620-8.
Corradini ML, Fioretti S, Leo T, Piperno R, Early recognition of postural disorders in multiple sclerosis through movement analysis: a modeling study, IEEE Trans Biomed Eng 44 (1997), 1029-38.
Sacco R, Bussman R, Oesch P, Kesselring J, Beer S, Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trial, J Neurol 258(5) (May 2011), 889-94. Epub 2010 Nov 15.
Goodman AD, Brown TR, Edwards KR, Krupp LB, Schapiro RT, Cohen R, Marinucci LN, Blight AR, A phase 3 trial of extended release oral dalfampridine in multiple sclerosis, Ann Neurol 68 (2010), 494-502.
Belachew S, Phan-Ba R, Bartholoḿe E, Delvaux V, Hansen I, Calay P, Hafsi KE, Moonen G, Tshibanda L, Vokaer M, Natalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsingremitting multiple sclerosis, Eur J Neurol 18(2) (Feb 2011), 240-5. doi: 10.1111/j.1468-1331.2010.03112.x.
Creange A, Serre I, Levasseur M, AudryD,Nineb A, Boerio D, Moreau T, Maison P, Walking capacities in multiple sclerosis measured by global positioning system odometer, Mult Scler 13 (2007), 220-3.
Gijbels D, Alders G, Van Hoof E, Charlier C, Roelants M, Broekmans T,Op 't Eijnde B, Feys P, Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures, Mult Scler 16 (2010), 618-26.
Givon U, Zeilig G, Achiron A, Gait analysis in multiple sclerosis: characterization of temporal-spatial parameters using GAITRite functional ambulation system, Gait Posture 29 (2009), 138-42.
Phan-Ba R, Pace A, Calay P, Grodent P, Douchamps F, Hyde R, Hotermans C, Delvaux V, Hansen I, Moonen G, Belachew S, Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis, Neurorehabil Neural Repair 25 (2011), 672-9.
Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, Syndulko K,Weinshenker BG, Antel JP, Confavreux C, Ellison GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson A,Willoughby E, Development of a multiple sclerosis functional composite as a clinical trial outcome measure, Brain 122 (Pt 5) (1999), 871-82.
Fischer JS, Rudick RA, Cutter GR, Reingold SC, The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force, Mult Scler 5 (1999), 244-50.
Phan-Ba R, Pace A, Calay P, Grodent P, Douchamps F, Hyde R, Hotermans C, Delvaux V, Hansen I, Moonen G, Belachew S, Comparison of the Timed 25-Foot and the 100-Meter Walk as Performance Measures in Multiple Sclerosis, Neurorehabil Neural Repair (2011).
Graham JE, Ostir GV, Fisher SR, Ottenbacher KJ, Assessing walking speed in clinical research: a systematic review, J Eval Clin Pract 14 (2008), 552-62.
Graham JE, Ostir GV, Kuo YF, Fisher SR, Ottenbacher KJ, Relationship between test methodology and mean velocity in timed walk tests: a review, Arch Phys Med Rehabil 89 (2008), 865-72.
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD,Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS, Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria, Ann Neurol 69 (2011), 292-302.
Hamilton F, Rochester L, Paul L, Rafferty D, O'Leary CP, Evans JJ, Walking and talking: an investigation of cognitivemotor dual tasking in multiple sclerosis, Mult Scler 15(10) (Oct 2009), 1215-27. Epub 2009 Aug 10.
Schulz D, Kopp B, Kunkel A, Faiss JH, Cognition in the early stage of multiple sclerosis, J Neurol 253 (2006), 1002-10.
Potagas C, Giogkaraki E, Koutsis G, Mandellos D, Tsirempolou E, Sfagos C, Vassilopoulos D, Cognitive impairment in different MS subtypes and clinically isolated syndromes, J Neurol Sci 267 (2008), 100-6.
Phan-Ba R, Calay P, Grodent P, Delrue G, Nagels G, Belachew S.Walking endurance assessment by a deceleration index calculated from performances on short and long distance walking tests in multiple sclerosis. American Academy of Neurology 63rd Annual Meeting. Hawä? Convention Center, Honolulu, Hawä? 2011.
Schwid SR, Thornton CA, Pandya S, Manzur KL, Sanjak M, Petrie MD, McDermott MP, Goodman AD, Quantitative assessment of motor fatigue and strength inMS, Neurology 53 (1999), 743-50.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
